Trial reportThe Journal of nutrition2026
The Effect of Three Daily Servings of Full-Fat Dairy for 12 Weeks on Body Weight, Body Composition, Energy Metabolism, Blood Lipids, and Dietary Intake of Adults with Overweight and Obesity.
Trial report in The Journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04399460 (The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control
Who cites it
1 citing paper in PubMed.
- Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHabitual dairy consumption reduces risk factors for obesity and its associated characteristics of the metabolic syndrome.
objectivesThis study aims to describe the effect of adding 3 daily servings of full-fat dairy to the diet of adults with overweight and obesity, counseled to follow Canada's Food Guide (CFG).
methodsA 12-wk single-blinded, parallel, randomized study was conducted in 74 participants [age: 36.55 ± 1.04 y; body mass index (BMI): 29.34 ± 0.43 kg/m
resultsBody weight and BMI were reduced by treatment (P < 0.05) in LD-ER over the 12 wk (P > 0.05). In 3D-AL, a decrease (0.25 ± 0.34 cm) in hip circumference (P < 0.05) and in systolic blood pressure (2.72 ± 2.18; P < 0.05; SBP) was found at week 12. SBP also decreased in LD-ER (P < 0.05). Triglycerides increased in all groups at week 4 (P < 0.05) but returned to baseline by week 12. Neither treatment nor time affected waist circumference, fat and fat-free mass, resting metabolic rate, fasting blood cholesterol, and urine creatinine and urea (P > 0.05). Protein and calcium (P < 0.04) intakes were increased with time in 3D-EN and 3D-AL but not in LD-ER. Compliance with CFG, assessed by a food tracker, increased with time (77% by week 12).
conclusionsFrequent and daily consumption of full-fat dairy as part of a healthy diet is consistent with CFG. This study was registered at clinicaltrials.gov as NCT04399460 on 22 May, 2020 (https://www. CLINICALTRIALS: gov/study/NCT04399460).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.